Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Vinorelbine for Children With Recurrent Anaplastic Large Cell Lymphoma

NCT03397953 is registered in ClinicalTrials.gov with Children's Cancer Group, China as lead sponsor.

NCT NCT03397953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03397953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Vinorelbine for Children With Recurrent Anaplastic Large Cell Lymphoma
Lead sponsor
Children's Cancer Group, China
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2016
Completion date
July 31, 2022
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic large cell lymphoma, vinorelbine